XML 27 R47.htm IDEA: XBRL DOCUMENT v3.3.0.814
COMMON STOCK (Details)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Apr. 29, 2015
$ / shares
shares
Mar. 01, 2015
USD ($)
shares
Feb. 24, 2015
USD ($)
Director
shares
Jan. 02, 2014
USD ($)
Director
shares
Sep. 30, 2015
USD ($)
shares
Mar. 31, 2015
USD ($)
Sep. 30, 2014
USD ($)
Jun. 30, 2015
USD ($)
Sep. 30, 2015
USD ($)
shares
Sep. 30, 2014
USD ($)
shares
Dec. 31, 2014
shares
Jan. 08, 2015
shares
Dec. 31, 2013
shares
Subsidiary, Sale of Stock [Line Items]                          
Share-based compensation expense | $           $ 128,880   $ 3,749,259 $ 5,047,580 $ 1,152,451      
Warrants exercised for cash (in shares)                 0 0      
Exercised stock options for cash (in shares)                 0 0      
Cashless stock options exercised (in shares)                 0 0      
Reduced exercise price (in dollars per share) | $ / shares $ 0.00005                        
Percentage of warrants receive common stock in exchange 17.50%                        
Extension term of warrants to waive anti-dilution rights 2 years                        
Number of warrants outstanding (in shares) 55,334,490                        
Class of warrant or right outstanding associated with anti-dilutive provision (in shares) 38,888,147                        
Loss on exchange of warrants | $         $ 0   $ 0   $ (12,959,654) $ 0      
Restricted Shares of Common Stock [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares issued for services (in shares)   400,000               0      
Consulting agreement termination date                 Mar. 01, 2016        
Common stock valued | $   $ 104,000                      
Common Stock [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Cashless exercise of warrants (in shares)                   0      
Class of warrant or right outstanding associated with anti-dilutive provision (in shares)                       15,512,057  
Warrants issued to purchase common stock (in shares)                       54,400,204  
Warrant [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Warrants exercised for cash (in shares)                 53,095,204   0    
Cashless exercise of warrants (in shares)                 0   0    
Number of warrants outstanding (in shares)         49,408,375       49,408,375   16,446,351   16,688,265
Warrants issued to purchase common stock (in shares)         49,283,205       49,283,205        
Alternative (1) [Member] | Common Stock [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Warrants issued to purchase common stock (in shares)         52,110,896       52,110,896        
Alternative (2) [Member] | Warrant [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Warrants issued to purchase common stock (in shares)         318,750       318,750        
Alternative (3) [Member] | Common Stock [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Warrants issued to purchase common stock (in shares)         974,826       974,826        
Alternative (3) [Member] | Warrant [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Warrants issued to purchase common stock (in shares)         73,125       73,125        
Non-Executive Directors [Member]                          
Subsidiary, Sale of Stock [Line Items]                          
Shares issued for services (in shares)     576,924 285,716                  
Number of non executive directors | Director     3 4                  
Shares issued for services per director (in shares)     192,308 71,429                  
Share-based compensation expense | $     $ 150,000 $ 160,001